News

The compound which is a DNA minor groove binder is currently in pre-clinical development with IND filing targeted for the third quarter of 2012. Almac Operations VP Rick

The FDA-approved Soltamox is used primarily for the chronic treatment of breast cancer or for prevention in certain susceptible breast cancer subgroups. Under the terms of the merger

Voraxaze is used to treat toxic plasma methotrexate concentrations in patients with delayed methotrexate clearance due to impaired renal function. The approval of Voraxaze was granted under priority

Antares oxybutynin gel 3% is a topical, translucent hydroalcoholic gel containing oxybutynin, an antispasmodic, antimuscarinic agent and is indicated for the treatment of (OAB). The FDA approved oxybutynin

CDX-301 is soluble, recombinant human FMS-like tyrosine kinase 3 ligand (Flt3L) that stimulates the expansion and differentiation of hematopoietic progenitor and stem cells. The dose-escalating Phase 1 study

Currently, Latanoprost is available as Xalatan (Latanoprost) from Pfizer, and is now introduced by Teva to fulfil generic prescriptions. Teva commercial director Kim Innes said this is the

The collaboration intends to create novel chemotherapeutic products exhibiting an enhanced safety and efficacy profile by selectively targeting inactive cytotoxic compounds toward tumor cells. The deal makes use

Alferon LDO (Human Leukocyte Derived) is an experimental low-dose, oral liquid formulation of Natural Alpha Interferon, and, like Alferon N Injection, should not cause antibody formation, which is

The New Drug Application (NDA) filing for Regnite was backed by the safety and efficacy data from the Phase 2 study in RLS patients. The long-term safety study